Brief: Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial

Syntara

04/10/2021 23:17

Oct 5 (Reuters) - Pharmaxis Ltd  PXS.AX :
    * CLEARED TO PROGRESS TO PHASE 2 BONE MARROW CANCER TRIAL

Source text for Eikon:  ID:nASX34HX86 
Further company coverage:  PXS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))